Diagnosis and treatment of malignant neoplasms

Details for Australian Patent Application No. 2002303802 (hide)

Owner Rhode Island Hospital, A Lifespan Partner Panacea Pharmaceuticals, Inc

Inventors Deutch, Alan, H.; Wands, Jack, R.; De La Monte, Suzanne; GhanbariI, Hossein, A.

Agent Cullen & Co

Pub. Number AU-B-2002303802

PCT Number PCT/US02/15814

PCT Pub. Number WO2002/092782

Priority 09/859,604 17.05.01 US

Parent 783327

Filing date 17 May 2002

Wipo publication date 25 November 2002

Acceptance publication date 27 November 2008

International Classifications

G01N 33/543 (2006.01) Investigating or analysing materials by specific methods not covered by groups - with an insoluble carrier for immobilising immunochemicals

A61K 39/395 (2006.01) Medicinal preparations containing antigens or antibodies - Antibodies

A61K 47/48 (2006.01) Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives - the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates

A61K 49/00 (2006.01) Preparations for testing

A61K 49/16 (2006.01) Preparations for testing

A61K 51/00 (2006.01) Preparations containing radioactive substances for use in therapy or testing

A61K 51/10 (2006.01) Preparations containing radioactive substances for use in therapy or testing

A61P 35/00 (2006.01) Antineoplastic agents

C07K 16/40 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies - against enzymes

C12N 5/10 (2006.01) Undifferentiated human, animal or plant cells, e.g. cell lines - Cells modified by introduction of foreign genetic material, e.g. virus-transformed cells

C12N 9/02 (2006.01) Enzymes, e.g. ligases (6.) - Oxidoreductases (1.), e.g. luciferase

C12N 9/06 (2006.01) Enzymes, e.g. ligases (6.) - acting on nitrogen containing compounds as donors (1.4, 1.5, 1.7)

C12N 15/09 (2006.01) Mutation or genetic engineering - Recombinant DNA-technology

C12P 21/08 (2006.01) Preparation of peptides or proteins - Monoclonal antibodies

G01N 33/574 (2006.01) Investigating or analysing materials by specific methods not covered by groups - for cancer

Event Publications

12 December 2002 Complete Application Filed

  Priority application(s): 09/859,604 17.05.01 US

1 May 2003 Application Open to Public Inspection

  Published as AU-B-2002303802

28 July 2005 Amendment Made

  The nature of the amendment is: Add coapplicant name Panacea Pharmaceuticals, Inc

27 November 2008 Application Accepted

  Published as AU-B-2002303802

18 December 2008 Corrigenda

  Applications Accepted - Name Index Under the name Rhode Island Hospital, A Lifespan Partner and Panacea Pharmaceuticals, Inc, Application No. 2002303802, under INID(72) correct the co-inventor name to Ghanbari, Hossein, A.

26 March 2009 Standard Patent Sealed

2 June 2011 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2002303803-SYSTEM AND METHOD FOR EN- CODING AND DECODING DATA FILES

2002303801-METHOD AND APPARATUS FOR FAULT TOLERANT AND FLEXIBLE TEST SIGNATURE GENERATOR